Pharmacokinetics, safety and efficacy of pegfilgrastim in dose-dense, sequential adjuvant chemotherapy for patients with breast cancer (BC)

被引：0
|
作者：
Atassi, Z.
Heilmann, V.
Hauser, N.
Hartmann, P. C.
Kreienberg, R.
Kurzeder, C.
机构：
[1] Univ Womens Hosp, Ulm, Germany
[2] Amgen Gmbh, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.13546
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
13546
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effects of pegfilgrastim administration on neutrophil apoptosis in breast cancer patients treated with dose-dense chemotherapy regimens
    Travaglino, E.
    Grasso, D.
    Bencardino, K.
    Manzoni, M.
    Rovati, B.
    Danova, M.
    Invernizzi, R.
    CYTOMETRY PART A, 2008, 73A (01) : 66 - 66
  • [22] Safety and efficacy of neo-adjuvant sequential dose-dense chemotherapy doublets combined with trastuzumab in patients with HER-2-positive early stage breast cancer
    Sanchez-Munoz, Alfonso
    Garcia-Tapiador, Ana Maria
    Duenas-Garcia, Rosario
    Jaen-Morago, Ana
    Ortega-Granados, Ana Laura
    Martinez-Ortega, Esther
    Fernandez Morales, Margarita
    Fernandez-Navarro, Monica
    de la Torre Cabrera, Capilla
    Duenas, Basilio
    Urena, Crisostomo
    Martinez, Julia
    Morales, Francisco
    Ramirez-Tortosa, Cesar
    Sanchez-Rovira, Pedro
    BREAST JOURNAL, 2008, 14 (05): : 506 - 507
  • [23] Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast Cancer
    Takabatake, Daisuke
    Kajiwara, Yukiko
    Ohtani, Shoichiro
    Suzuki, Yoko
    Yamamoto, Mari
    Kubo, Shinichiro
    Ikeda, Masahiko
    Takahashi, Mina
    Hara, Fumikata
    Aogi, Kenjiro
    Ohsumi, Shozo
    Ogasawara, Yutaka
    Nishiyama, Yoshitaka
    Hikino, Hajime
    Matsuoka, Kinya
    Shien, Tadahiko
    Taira, Naruto
    Doihara, Hiroyoshi
    ACTA MEDICA OKAYAMA, 2021, 75 (03) : 357 - 362
  • [24] Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer
    George Fountzilas
    Dimitrios Pectasides
    Christos Christodoulou
    Eleni Timotheadou
    Theofanis Economopoulos
    Pavlos Papakostas
    Christos Papadimitriou
    Helen Gogas
    Ioannis Efstratiou
    Dimosthenis Skarlos
    Medical Oncology, 2006, 23 : 479 - 488
  • [25] Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer
    Fountzilas, George
    Pectasides, Dimitrios
    Christodoulou, Christos
    Timotheadou, Eleni
    Economopoulos, Theofanis
    Papakostas, Pavlos
    Papadimitriou, Christos
    Gogas, Helen
    Efstratiou, Ioannis
    Skarlos, Dimosthenis
    MEDICAL ONCOLOGY, 2006, 23 (04) : 479 - 488
  • [26] Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer
    Razis, E
    Dimopoulus, AM
    Bafaloukos, D
    Papadimitriou, C
    Kalogera-Fountzila, A
    Kalofonos, H
    Briassoulis, E
    Samantas, E
    Keramopoulos, A
    Pavlidis, N
    Kosmidis, P
    Fountzilas, G
    CANCER INVESTIGATION, 2001, 19 (02) : 137 - 144
  • [27] Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer
    Fountzilas, G
    Papadimitriou, C
    Aravantinos, G
    Nicolaides, C
    Stathopoulos, G
    Bafaloukos, D
    Kalofonos, H
    Ekonomopoulos, T
    Skarlos, D
    Pavlidis, N
    Dimopoulos, AM
    ONCOLOGY, 2001, 60 (03) : 214 - 220
  • [28] Safety and tolerance of dose-dense Epirubicin and Cyclophosphamide (EC) with Pegfilgrastim for Japanese patients with early breast cancer
    Watanabe, K.
    Yamamoto, M.
    Sato, M.
    Tomioka, N.
    Takahashi, M.
    BREAST, 2017, 32 : S27 - S28
  • [29] HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients
    L Del Mastro
    P Bruzzi
    G Nicolò
    G Cavazzini
    A Contu
    M D'Amico
    A Lavarello
    F Testore
    B Castagneto
    E Aitini
    L Perdelli
    C Bighin
    R Rosso
    Marco Venturini
    British Journal of Cancer, 2005, 93 : 7 - 14
  • [30] HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients
    Del Mastro, L
    Bruzzi, P
    Nicolò, G
    Cavazzini, G
    Contu, A
    D'Amico, M
    Lavarello, A
    Testore, F
    Castagneto, B
    Aitini, E
    Perdelli, L
    Bighin, C
    Rosso, R
    Venturini, M
    BRITISH JOURNAL OF CANCER, 2005, 93 (01) : 7 - 14
12345